Rare Disease Trial, Recruiting NCT06875089 Sponsor: Centre Hospitalier Universitaire Dijon Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT06875089
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the satisfaction/information part of the study (parents or legal guardians):

  • You are an expectant parent whose unborn child will receive care at one of the participating maternity units
  • At least one parent or legal guardian has been given information about the study
  • You are willing to allow your data to be used in the study
  • You are covered by, or entitled to benefits from, a social security system

For the newborn genetic screening part of the study (babies):

  • Your baby was born at one of the participating centers, or was born elsewhere but will be cared for at a participating center
  • Your baby is less than 28 days old at the time the first screening sample (blotting paper) is collected

For the newborn genetic screening part of the study (parents or legal guardians):

  • At least one biological parent has been given information about the study
  • You do not object to standard newborn screening tests
  • At least one parent or legal guardian is able to give consent for the baby to be tested
  • At least one parent or legal guardian has signed a consent form
  • The second parent or legal guardian has agreed to testing (unless they are unknown or cannot be contacted), as confirmed by the first parent or legal guardian
  • You are covered by, or entitled to benefits from, a social security system

Who may not be able to join:

Parents or legal guardians:

  • Parents or legal guardians who are under a legal protection order, such as guardianship or court-ordered supervision

Babies:

  • Babies born under anonymous birth circumstances as defined by French law (known as "nés sous X")

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0380295313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire Dijon
Registry
ClinicalTrials.gov
Start date
5 May 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

parents who have accepted the pGS-NBS for their children for Treatable list; results concerning the Treatable list returned to clinicians within 4 weeks following the sample

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov